首页|王书臣教授辨证治疗肺痿经验

王书臣教授辨证治疗肺痿经验

扫码查看
特发性肺间质纤维化(Idiopathic pulmonary fibrosis,IPF)已成为国际化难题,患者多病情进展迅速、生活质量低下、生存期短,单用西医激素和免疫抑制剂或细胞因子抑制剂治疗,难以延缓或逆转肺纤维化的进展,同时诸多药物反应限制其应用.通过中医辨证论治结合现代中药药理,王书臣教授对特发性肺间质纤维化的中医病名、病因病机及治疗原则形成了自己独特的见解,认为重症患者当以"肺痿"命名更佳,提出"治肺痿如治中风""治肺痿当祛风""治痿当兼顾脾胃""肺肾同治"等观点,临床中用于患者治疗,疗效确切,为提高患者生活质量提供了宝贵经验.
Professor Wang Shuchen's Experience in Dialectical Treatment of Pulmonary Impo-tence
Idiopathic pulmonary fibrosis(IPF)has become an international problem,with patients often experien-cing rapid disease progression,poor quality of life,and short survival periods.Treatment with Western medicine alone,such as corticosteroids,immunosuppressants,or cytokine inhibitors,has proven difficult to delay or reverse the progression of pul-monary fibrosis,and the limitations of various drug reactions restrict their application.Through the combination of tradition-al Chinese medicine(TCM)syndrome differentiation and modern pharmacology,Professor Wang Shu-chen has developed his unique insights into the TCM name,etiology,pathogenesis,and treatment principles of IPF.He suggests that for severe cases,naming it as"consumptive lung disease"may be more appropriate.He proposes viewpoints such as"treating con-sumptive lung disease as stroke","dispelling wind evil in the treatment of consumptive lung disease","considering the spleen and stomach during the treatment of consumptive lung disease",and"treating the lung and kidney simultaneously".These perspectives have been applied in clinical practice with significant efficacy,providing valuable experience in impro-ving the quality of life for patients.

Idiopathic Pulmonary FibrosisConsumptive Lung DiseasePharmacologyTreatment ExperienceProven Cases

韦建国、易亮、王书臣

展开 >

中国中医科学院西苑医院急诊科,北京 100091

特发性肺间质纤维化 肺痿 药理 治疗体会 验案

全国中医临床特色技术传承骨干人才项目

国中医药人教函201936号

2024

世界中西医结合杂志
中华中医药学会

世界中西医结合杂志

CSTPCD
影响因子:1.053
ISSN:1673-6613
年,卷(期):2024.19(2)
  • 23